how the treatment of dlbcl and fl are changing in the uk
Published 2 years ago • 767 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
6:33
new data on dlbcl in the uk and its impact on treatment decisions
-
1:56
the need for new treatment strategies for patients with dlbcl
-
1:45
improving the frontline treatment of dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
4:46
current treatment options for older patients with dlbcl
-
29:38
dlbcl treatment approaches: what you need to know
-
12:05
how to clean/change biobase hematology valves
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
1:52
an insight into the optimal management of patients with dlbcl
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
2:27
elucidating the genetic and molecular basis of dlbcl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
2:04
an insight into how bispecifics are changing the lymphoma treatment landscape
-
5:24
treatment strategies for patients with dlbcl who relapse after car-t therapy
-
1:31
the current state of treatment for limited-stage dlbcl
-
4:00
current treatment landscape of dlbcl
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
1:23
defining elderly patients in the context of dlbcl treatment
-
2:03
novel treatment approaches for early-stage dlbcl
-
1:34
updated bsh guidelines for managing dlbcl